Table 1. Point-of-care Testing (POCT) for Infectious Diseases Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Point-of-care Testing (POCT) for Infectious Diseases Market Restraints

Table 3. Point-of-care Testing (POCT) for Infectious Diseases Market Trends

Table 4. Point-of-care Testing (POCT) for Infectious Diseases Industry Policy

Table 5. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue Share by Company, 2019-2024, Ranked by Data of 2024

Table 7. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 9. Global Point-of-care Testing (POCT) for Infectious Diseases Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Point-of-care Testing (POCT) for Infectious Diseases Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Point-of-care Testing (POCT) for Infectious Diseases Mergers & Acquisitions, Expansion Plans

Table 12. Global Point-of-care Testing (POCT) for Infectious Diseases Manufacturers Product Type

Table 13. Head Office and Point-of-care Testing (POCT) for Infectious Diseases Production Site of Key Manufacturer

Table 14. Point-of-care Testing (POCT) for Infectious Diseases Capacity of Major Manufacturers and Future Plan

Table 15. China Point-of-care Testing (POCT) for Infectious Diseases Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 16. China Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 17. China Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 18. Global Point-of-care Testing (POCT) for Infectious Diseases Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Point-of-care Testing (POCT) for Infectious Diseases Production by Region, 2019-2024, (K Units)

Table 20. Global Point-of-care Testing (POCT) for Infectious Diseases Production Forecast by Region, 2024-2030, (K Units)

Table 21. Global Key Players of Point-of-care Testing (POCT) for Infectious Diseases Upstream (Raw Materials)

Table 22. Global Point-of-care Testing (POCT) for Infectious Diseases Typical Customers

Table 23. Point-of-care Testing (POCT) for Infectious Diseases Typical Distributors

Table 24. By Type, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2019-2030

Table 34. Roche Company Information, Head Office, Market Area, and Industry Position

Table 35. Roche Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 36. Roche Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. Roche Company Profile and Main Business

Table 38. Roche Recent Developments

Table 39. Abbott Company Information, Head Office, Market Area, and Industry Position

Table 40. Abbott Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 41. Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Abbott Company Profile and Main Business

Table 43. Abbott Recent Developments

Table 44. Siemens Healthineers Company Information, Head Office, Market Area, and Industry Position

Table 45. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 46. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Siemens Healthineers Company Profile and Main Business

Table 48. Siemens Healthineers Recent Developments

Table 49. Danaher Company Information, Head Office, Market Area, and Industry Position

Table 50. Danaher Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 51. Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Danaher Company Profile and Main Business

Table 53. Danaher Recent Developments

Table 54. BD Company Information, Head Office, Market Area, and Industry Position

Table 55. BD Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 56. BD Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. BD Company Profile and Main Business

Table 58. BD Recent Developments

Table 59. Assure Tech Company Information, Head Office, Market Area, and Industry Position

Table 60. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 61. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Assure Tech Company Profile and Main Business

Table 63. Assure Tech Recent Developments

Table 64. BioMerieux Company Information, Head Office, Market Area, and Industry Position

Table 65. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 66. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. BioMerieux Company Profile and Main Business

Table 68. BioMerieux Recent Developments

Table 69. Bio-Rad Laboratories Company Information, Head Office, Market Area, and Industry Position

Table 70. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 71. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Bio-Rad Laboratories Company Profile and Main Business

Table 73. Bio-Rad Laboratories Recent Developments

Table 74. Wondfo Company Information, Head Office, Market Area, and Industry Position

Table 75. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 76. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Wondfo Company Profile and Main Business

Table 78. Wondfo Recent Developments

Table 79. Wuhan Easy Diagnosis Company Information, Head Office, Market Area, and Industry Position

Table 80. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 81. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Wuhan Easy Diagnosis Company Profile and Main Business

Table 83. Wuhan Easy Diagnosis Recent Developments

Table 84. Getein Biotech Company Information, Head Office, Market Area, and Industry Position

Table 85. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 86. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Getein Biotech Company Profile and Main Business

Table 88. Getein Biotech Recent Developments

Table 89. Beijing Hotgen Biotech Co.,ltd. Company Information, Head Office, Market Area, and Industry Position

Table 90. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 91. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Beijing Hotgen Biotech Co.,ltd. Company Profile and Main Business

Table 93. Beijing Hotgen Biotech Co.,ltd. Recent Developments

Table 94. Beijing Wantai BioPharm Company Information, Head Office, Market Area, and Industry Position

Table 95. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 96. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Beijing Wantai BioPharm Company Profile and Main Business

Table 98. Beijing Wantai BioPharm Recent Developments

Table 99. Zhejiang Orient Gene Biotech Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 100. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 101. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Zhejiang Orient Gene Biotech Co.,Ltd. Company Profile and Main Business

Table 103. Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments

Table 104. Sansure Biotech Inc. Company Information, Head Office, Market Area, and Industry Position

Table 105. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Models, Specifications, and Application

Table 106. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Sansure Biotech Inc. Company Profile and Main Business

Table 108. Sansure Biotech Inc. Recent Developments

List of Figures

Figure 1. Point-of-care Testing (POCT) for Infectious Diseases Picture

Figure 2. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Point-of-care Testing (POCT) for Infectious Diseases Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Point-of-care Testing (POCT) for Infectious Diseases Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units) & (2019-2030)

Figure 7. China Point-of-care Testing (POCT) for Infectious Diseases Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Point-of-care Testing (POCT) for Infectious Diseases Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Point-of-care Testing (POCT) for Infectious Diseases Market Share of Global, 2019-2030

Figure 10. Global Point-of-care Testing (POCT) for Infectious Diseases Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Point-of-care Testing (POCT) for Infectious Diseases Key Participants, Market Share, 2024

Figure 12. Global Point-of-care Testing (POCT) for Infectious Diseases Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Point-of-care Testing (POCT) for Infectious Diseases Capacity Market Share by Region, 2024 VS 2030

Figure 14. Global Point-of-care Testing (POCT) for Infectious Diseases Production Market Share & Forecast by Region, 2019-2030

Figure 15. Point-of-care Testing (POCT) for Infectious Diseases Industry Chain

Figure 16. Point-of-care Testing (POCT) for Infectious Diseases Procurement Model

Figure 17. Point-of-care Testing (POCT) for Infectious Diseases Sales Model

Figure 18. Point-of-care Testing (POCT) for Infectious Diseases Sales Channels, Direct Sales, and Distribution

Figure 19. Based on Colloidal Gold

Figure 20. Based on Chemiluminescence

Figure 21. Based on Fluorescence Immunochromatography

Figure 22. Other

Figure 23. By Type, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value, 2019-2030, US$ Million

Figure 24. By Type, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share, 2019-2030

Figure 25. By Type, Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 26. By Type, Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2019-2030

Figure 27. By Type, Global Point-of-care Testing (POCT) for Infectious Diseases Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 28. Hospital

Figure 29. lndependent Testing Organization

Figure 30. By Application, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value, 2019-2030, US$ Million

Figure 31. By Application, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share, 2019-2030

Figure 32. By Application, Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 33. By Application, Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2019-2030

Figure 34. By Application, Global Point-of-care Testing (POCT) for Infectious Diseases Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 35. By Region, Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share, 2019-2030

Figure 36. By Region, Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2019-2030

Figure 37. North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 38. By Country, North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share, 2024

Figure 39. Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 40. By Country, Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share, 2024

Figure 41. Asia Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 42. By Country/Region, Asia Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share, 2024

Figure 43. South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 46. U.S. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 47. By Type, U.S. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 48. By Application, U.S. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 49. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 50. By Type, Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 51. By Application, Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 52. China Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 53. By Type, China Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 54. By Application, China Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 55. Japan Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 56. By Type, Japan Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 57. By Application, Japan Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 58. South Korea Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 59. By Type, South Korea Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 60. By Application, South Korea Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 61. Southeast Asia Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 62. By Type, Southeast Asia Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 63. By Application, Southeast Asia Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 64. India Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 65. By Type, India Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 66. By Application, India Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, 2019-2030, (K Units)

Figure 68. By Type, Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 69. By Application, Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up and Top-down Approaches

Figure 73. Top-down Approaches